Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed Glioblastoma”

88 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 88 results

Early research (Phase 1)Study completedNCT01238237
What this trial is testing

Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AA

Who this might be right for
Glioblastoma Multiforme (GBM)ANAPLASTIC ASTROCYTOMA (AOA)GBM+1 more
Northwell Health 15
Testing effectiveness (Phase 2)Study completedNCT04238819
What this trial is testing

Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma

Who this might be right for
Relapsed Solid TumorRefractory Solid Tumor
Eli Lilly and Company 47
Early research (Phase 1)Ended earlyNCT00112619
What this trial is testing

Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsCarcinoma of Unknown PrimaryLeukemia+2 more
Pediatric Brain Tumor Consortium 19
Large-scale testing (Phase 3)Study completedNCT00003293
What this trial is testing

SU-101 Compared With Procarbazine in Treating Patients With Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Pfizer
Testing effectiveness (Phase 2)Study completedNCT00116376
What this trial is testing

Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM)

Who this might be right for
Glioblastoma Multiforme
Novartis Pharmaceuticals 64
Early research (Phase 1)Study completedNCT01390571
What this trial is testing

Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma

Who this might be right for
Brain and Central Nervous System Tumors
Cancer Research UK 34
Early research (Phase 1)Study completedNCT01076530
What this trial is testing

Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors

Who this might be right for
Childhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Embryonal Tumor+31 more
National Cancer Institute (NCI) 27
Early research (Phase 1)Study completedNCT00053963
What this trial is testing

FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia

Who this might be right for
Blastic Phase Chronic Myelogenous LeukemiaChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+22 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT01112527
What this trial is testing

PF-00299804 in Adult Patients With Relapsed/Recurrent Glioblastoma

Who this might be right for
GlioblastomaGBMGlioblastoma Multiforme
Massachusetts General Hospital 58
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Early research (Phase 1)Study completedNCT03603379
What this trial is testing

Doxorubicin-loaded Anti-EGFR-immunoliposomes (C225-ILs-dox) in High-grade Gliomas

Who this might be right for
Glioblastoma
University Hospital, Basel, Switzerland 9
Not applicableStudy completedNCT04610229
What this trial is testing

Safety of IMRT Treatment With Inhomogeneous Dose in Patients With Relapsed High-grade Gliomas.

Who this might be right for
Glioblastoma MultiformeGlioblastomaGlioblastoma, Adult
Azienda USL Reggio Emilia - IRCCS 12
Testing effectiveness (Phase 2)Ended earlyNCT01068782
What this trial is testing

Multiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second Relapse

Who this might be right for
Astrocytic Tumors
Exelixis 19
Early research (Phase 1)Study completedNCT03224104
What this trial is testing

Multi-kinase Inhibitor TG02 (TG02) in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma.

Who this might be right for
Astrocytoma, Grade IIIGlioblastoma
European Organisation for Research and Treatment of Cancer - EORTC 71
Testing effectiveness (Phase 2)Study completedNCT02750891
What this trial is testing

DSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade Gliomas

Who this might be right for
GlioblastomaDiffuse Intrinsic Pontine Glioma
Sumitomo Pharma Co., Ltd. 18
Not applicableLooking for participantsNCT06430424
What this trial is testing

Study of Metabolic, Transcriptomic and Proteomic Characteristics in Relapsed Glioblastoma

Who this might be right for
Relapsed CancerGlioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
University Hospital, Bordeaux 40
Testing effectiveness (Phase 2)Study completedNCT00337883
What this trial is testing

The Safety and Efficacy of Tarceva in Patients With First Relapse of Grade IV Glioma (Glioblastoma Multiforme)

Who this might be right for
Glioblastoma
Genentech, Inc. 110
Not applicableStudy completedNCT01929720
What this trial is testing

Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors

Who this might be right for
Anxiety DisorderWorryUncertainty+19 more
Ohio State University Comprehensive Cancer Center 33
Early research (Phase 1)Study completedNCT00003876
What this trial is testing

Internal Radiation Therapy Plus Carmustine Implants in Treating Patients With Recurrent or Refractory Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Barrett Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT01517776
What this trial is testing

Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and Adolescents

Who this might be right for
Gliomas
Martin-Luther-Universität Halle-Wittenberg 28
Load More Results